Author

Hanbyeol Kim

Institution: National Cancer Center

Observed institutions: Seoul National University, National Cancer Center, Hanyang University, Dankook University

ORCID: 0000-0001-5149-220X

Observed ORCID: 0000-0001-5149-220X

OpenAlex ID: A5082520346

Cell-intrinsic PD-L1 signaling drives immunosuppression by myeloid-derived suppressor cells through IL-6/Jak/Stat3 in PD-L1-high lung cancer

2025 · Hyein Jeong, Jaemoon Koh, et al. · Journal for ImmunoTherapy of Cancer · 148

Role of lymphoid lineage cells aberrantly expressing alarmins S100A8/A9 in determining the severity of COVID-19

2022 · Joongho Lee, Hanbyeol Kim, et al. · Genes & Genomics · 10

Identification of ulcerative colitis-specific immune cell signatures from public single-cell RNA-seq data

2023 · Hanbyeol Kim, Hyo Keun Kim, et al. · Genes & Genomics · 8

Intravesical mitomycin-C administered immediately before transurethral resection of bladder tumor in non–muscle-invasive bladder cancer: Clinical outcomes and molecular predictors from over 3 years of extended follow-up in a phase II trial

2026 · Hye Won Lee, Geehyun Song, et al. · Korean journal of urology

Molecular profiling using next generation sequencing with high-purity enrichment of circulating tumor cells.

2024 · Jaesung Choi, Aejin Jeong, et al. · Journal of Clinical Oncology

Simultaneous detection of tumor-derived mutations in DNA and RNA extracted from a single circulating tumor cell based on droplet digital polymerase chain reaction.

2024 · Jaesung Choi, Sehwan Park, et al. · Journal of Clinical Oncology

Abstract 7503: Non-clinical study of circulating tumor cells in humanized mice: Post-xenograft effects in immunodeficient mice

2024 · Sehyung Pak, Hajin Pak, et al. · Cancer Research

Abstract 3691: Molecular profiling using next generation sequencing with high purity enrichment of circulating tumor cells

2024 · Sehwan Park, Jaesung Choi, et al. · Cancer Research

Works count: 8

Citation count: 166

H-index: 3

I10-index: 2